Recent publications

• Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report

  

  13-15 May 2019, Tbilisi, Georgia
  The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More

  10 July 2019

• Updated Hepatitis C Treatment Guidelines

  

  Geneva - July 2018
  The World Health Organization released the updated Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. They follow and update the screening and care section of the WHO Guidelines for the screening, care and treatment of (...) More

  8 November 2018

• Hepatitis C among People who use drugs 61th CND Side Event (March 2018)

  

  On March 16th, during the 61th Session of the Commission on Narcotic Drugs (CND) held in Vienna (Austria), a side event untitled “Hepatits C among people who use drugs – the global state and recommendations” was sponsored by the World Health Organization (WHO), Norway government, the International (...) More

  9 April 2018

• Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV

  

  This Training Manual was designed and updated in February 2018 by Treatment Action Group (TAG), an independent, activist and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for HIV, tuberculosis, and hepatitis C virus.
  The purpose (...) More

  22 February 2018

• Tackling hepatitis C – Pakistan’s road to success

  

  The annual World Hepatitis Summit in São Paulo, Brazil took place in November 2017 to take stock of the World Health Organization’s global health sector strategy on viral hepatitis 2016–2020. The international community called for immediate, innovative, and coherent policy interventions, backed by evidence-based research. In 2015, the viral hepatitis pandemic (largely hepatitis B and C) caused an estimated 1.4 million deaths, however, the attention and response by donors and policy-makers has been woefully inadequate. An Editorial in The Lancet draws attention to this inaction, and new data indicate that action has been fragmented and insufficient. Only 82 countries, including Pakistan, have adopted strategies to eliminate viral hepatitis by 2030. More

  13 March 2018